Peter M Roberts, 60Newton, MA

6370405, Apr 9, 2002

Jul 29, 1997

08/902421

Qi Li - Marlborough MA
Peter R. Roberts - Groton MA
Peter D. Antaya - Sutton MA
Jeffrey M. Seuntjens - Singapore, SG
Steven Hancock - Worcester MA
Kenneth L. DeMoranville - Jefferson MA
Craig J. Christopherson - Worcester MA
Jennifer H. Garrant - Natick MA
Christopher A. Craven - Bedford MA

American Superconductor Corporation - Westborough MA

H01B 1202

505231, 505236, 505237, 505431, 505704, 1741251, 29599, 428702, 428930

A multifilamentary superconductor composite having a high fill factor is formed from a plurality of stacked monofilament precursor elements, each of which includes a low density superconductor precursor monofilament. The precursor elements all have substantially the same dimensions and characteristics, and are stacked in a rectilinear configuration and consolidated to provide a multifilamentary precursor composite. The composite is thereafter thermomechanically processed to provide a superconductor composite in which each monofilament is less than about 50 microns thick.

6436875, Aug 20, 2002

Mar 22, 2001

09/815063

Lawrence J. Masur - Needham MA
Donald R. Parker - Randolph MA
Eric R. Podtburg - Natick MA
Peter R. Roberts - Groton MA
Ronald D. Parrella - Shrewsbury MA
Steven Hancock - Worcester MA

American Superconductor Corporation - Westborough MA

C04B 3564

505500, 505433, 505501, 505742, 29599

The invention features high performing composite superconducting oxide articles that can be produced from OPIT precursors substantially without poisoning the superconductor. In general, the superconducting oxide is substantially surrounded by a matrix material. The matrix material contains a first constraining material including a noble metal and a second metal. The second metal is a relatively reducing metal which lowers the overall oxygen activity of the matrix material and the article at a precursor process point prior to oxidation of the second metal. The second metal is substantially converted to a metal oxide dispersed in the matrix during or prior to a first phase conversion heat treatment but after formation of the composite, creating an ODS matrix.

6458940, Oct 1, 2002

Jul 2, 1997

08/887497

Peter C. Roberts - Holliston MA
Bruce L. Frank - Marlborough MA
David E. Szymkowski - Mountain View CA
John S. Mills - Farnham Common, GB
John Goodchild - Westborough MA
Jia L. Wolfe - Somerville MA
Robert E. Kilkuskie - Shrewsbury MA
Isobel M. Greenfield - St. Albans, GB
Veronica Sullivan - St. Albans, GB

Hybridon, Inc. - Milford MA

C07H 2102

536 231, 536 243, 435 6

The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.

6509149, Jan 21, 2003

Jun 6, 1995

08/471974

Peter C. Roberts - Holliston MA
Bruce L. Frank - Marlborough MA
David E. Szymkowski - Herts, GB
John S. Mills - Garden City, GB
John Goodchild - Westborough MA
Jia L. Wolfe - Somerville MA
Robert E. Kilkuskie - Shrewsbury MA
Isobel M. Greenfield - Herts, GB
Veronica Sullivan - Herts, GB

Hybridon, Inc. - Cambridge MA

C12Q 170

435 5, 435 6, 536 231, 536 243, 514 44

The present invention discloses synthetic oligonucleotides complementary to a nucleic acid spanning the translational start site of human papillomavirus gene E1, and including at least 15 nucleotides. Also disclosed are methods and kits for inhibiting the replication of HPV, for inhibiting the expression of HPV nucleic acid and protein, for detection of HPV, and for treating HPV infections.

6576218, Jun 10, 2003

Oct 18, 2001

09/982465

Peter C. Roberts - Holliston MA
Samuel E. Driver - Brighton MA

Quantitative Informational Knockout Technology - Providence RI

A61K 4800

424 91, 424 92, 514 44, 536 245

This invention provides synthetic oligonucleotides that are useful for transplacental delivery, the oligonucleotides being DNA or RNA or both, preferably between 12-35 nucleotides in length, having a stabilized and charged backbone and at least one chemically modified base or sugar moiety, wherein the modified base or sugar moiety facilitates transplacental delivery.

6762673, Jul 13, 2004

Jan 20, 2000

09/488742

Alexander Otto - Chelmsford MA
Ralph P. Mason - Chelmsford MA
Craig J. Christopherson - Worcester MA
Peter R. Roberts - Groton MA
Steven Fleshler - Brookline MA
Swarn S. Kalsi - Shrewsberry MA
Gregory L. Snitchler - Shrewsberry MA
Robert C. Diehl - Holden MA
Dietrich Bonmann - Meckenheim, DE
Martin Lakner - Bimenstorf, DE
Willi Paul - Wettingen, DE
Harry Zueger - Geneva, CH

American Superconductor Corp. - Westborough MA
ABB Transmission Distribution Technologies, Ltd. - Zurich

H01C 1014

338 32S, 338 13, 1741251, 505881

An elongated current limiting composite material comprising one or more high-temperature superconductor filaments and a second electrically conductive member, which may include a sheath of high bulk resistivity surrounding the filament. The current limiter exhibits dissipation in the range of 0. 05-0. 5 V/cm at currents of 3-10 times the operating current, thereby minimizing fault currents and improving recovery capability.

6984729, Jan 10, 2006

Jul 28, 1997

08/901612

Bruce L. Frank - Marlborough MA, US
Peter C. Roberts - Holliston MA, US
John Goodchild - Westborough MA, US
J. Charles Craig - Welwyn Garden, GB
John S. Mills - Welwyn Garden, GB
Andrew Slade - Welwyn Garden, GB
Robert E. Kilkuskie - Shrewsbury MA, US
Noel A. Roberts - Harpenden, GB
Raymond Jupp - Welwyn Garden, GB

Hybridon, Inc. - Cambridge MA

C07H 21/04

536 245, 536 231, 536 243, 536 2431, 536 2433

The present invention discloses synthetic oligonucleotides complementary to contiguous and noncontiguous regions of the HBV RNA. Also disclosed are methods and kits for inhibiting the replication and expression of HBV, and for treating HBV infections and associated conditions.

7672369, Mar 2, 2010

Feb 13, 2003

10/366756

Arman M. Garakani - Cambridge MA, US
Andrew A. Hack - Pride's Crossing MA, US
Peter Roberts - Dedham MA, US
Sean Walter - Needham MA, US

Reify Corporation - Cambridge MA

H04N 7/12
H04N 11/02
H04N 11/04
H04B 1/66

37524001

The present invention provides methods and apparatus for acquisition, compression, and characterization of spatiotemporal signals. In one aspect, the invention assesses self-similarity over the entire length of a spatiotemporal signal, as well as on a moving attention window, to provide cost effective measurement and quantification of dynamic processes. The invention also provides methods and apparatus for measuring self-similarity in spatiotemporal signals to characterize, adaptively control acquisition and/or storage, and assign meta-data for further detail processing. In some embodiments, the invention provides for an apparatus adapted for the characterization of biological units, and methods by which attributes of the biological units can be monitored in response to the addition or removal of manipulations, e. g. , treatments. The attributes of biological units can be used to characterize the effects of the abovementioned manipulations or treatments as well as to identify genes or proteins responsible for, or contributing to, these effects.